^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
DCISionRT

Company:
PreludeDx
Type:
Laboratory Developed Test
Related tests:

Details

Evidence
The DCISionRT test combines the latest innovations in molecular biology with artificial intelligence and machine learning to deliver the most advanced DCIS test available. DCISionRT is the first biological risk signature developed specifically for DCIS and the only test that predicts radiation therapy benefit. The test relies on a comprehensive assessment of the proven disease progression pathways in addition to standard clinical factors. Non-linear algorithms were developed using artificial intelligence and machine learning techniques.
Cancer:
Breast Cancer